149 related articles for article (PubMed ID: 29636621)
1. Antibody-sandwich ELISA analysis of a novel blood biomarker of CST4 in gastrointestinal cancers.
Dou Y; Lv Y; Zhou X; He L; Liu L; Li P; Sun Y; Wang M; Gao M; Wang C
Onco Targets Ther; 2018; 11():1743-1756. PubMed ID: 29636621
[TBL] [Abstract][Full Text] [Related]
2. The Diagnosis Significance of Serum Cysteine Protease Inhibitors (CST4) in Colorectal Cancer.
Huang M; Yang Z; Ren J; Wang T; Chen D; Zhan Y; Le W; Deng S
Technol Cancer Res Treat; 2023; 22():15330338231164232. PubMed ID: 37122229
[TBL] [Abstract][Full Text] [Related]
3. Combination of serum CST4 and DR-70 contributes to early diagnosis of colorectal cancer.
Cai L; Tu M; Yin X; Zhang S; Zhuang W; Xia Y; Zhang Y; Zhang L; Yu L; Chi L; Huang Y
Clin Chim Acta; 2022 Jun; 531():318-324. PubMed ID: 35500878
[TBL] [Abstract][Full Text] [Related]
4. Quantification of a panel for dry-eye protein biomarkers in tears: A comparative pilot study using standard ELISA and customized microarrays.
Benitez-Del-Castillo JM; Soria J; Acera A; Muñoz AM; Rodríguez S; Suárez T
Mol Vis; 2021; 27():243-261. PubMed ID: 34012227
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CST4 promotes gastric cancer aggressiveness by activating the ELFN2 signaling pathway.
Zhang YQ; Zhang JJ; Song HJ; Li DW
Am J Cancer Res; 2017; 7(11):2290-2304. PubMed ID: 29218251
[TBL] [Abstract][Full Text] [Related]
6. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
7. Cysteine protease inhibitor S promotes lymph node metastasis of esophageal cancer cells via VEGF-MAPK/ERK-MMP9/2 pathway.
Guo J; Song Z; Muming A; Zhang H; Awut E
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38386044
[TBL] [Abstract][Full Text] [Related]
8. Circulating Exosomal Gastric Cancer-Associated Long Noncoding RNA1 as a Biomarker for Early Detection and Monitoring Progression of Gastric Cancer: A Multiphase Study.
Guo X; Lv X; Ru Y; Zhou F; Wang N; Xi H; Zhang K; Li J; Chang R; Xie T; Wang X; Li B; Chen Y; Yang Y; Chen L; Chen L
JAMA Surg; 2020 Jul; 155(7):572-579. PubMed ID: 32520332
[TBL] [Abstract][Full Text] [Related]
9. Utility of slot-blot-ELISA as a new, fast, and sensitive immunoassay for detection of carcinoembryonic antigen in the urine samples of patients with various gastrointestinal malignancies.
El-Masry S; El-Sayed IH; Lotfy M; Mahmoud L; El-Naggar M
J Immunoassay Immunochem; 2007; 28(2):91-105. PubMed ID: 17424828
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
[TBL] [Abstract][Full Text] [Related]
11. CA72-4 combined with CEA, CA125 and CAl9-9 improves the sensitivity for the early diagnosis of gastric cancer.
Yang AP; Liu J; Lei HY; Zhang QW; Zhao L; Yang GH
Clin Chim Acta; 2014 Nov; 437():183-6. PubMed ID: 25086284
[TBL] [Abstract][Full Text] [Related]
12. Dermokine as a novel biomarker for early-stage colorectal cancer.
Tagi T; Matsui T; Kikuchi S; Hoshi S; Ochiai T; Kokuba Y; Kinoshita-Ida Y; Kisumi-Hayashi F; Morimoto K; Imai T; Imoto I; Inazawa J; Otsuji E
J Gastroenterol; 2010 Dec; 45(12):1201-11. PubMed ID: 20652332
[TBL] [Abstract][Full Text] [Related]
13. The role of
Hu H; Chen X; Wang C; Jiang Y; Li J; Ying X; Yang Y; Li B; Zhou C; Zhong J; Wu D; Ying J; Duan S
Oncotarget; 2017 Oct; 8(48):84054-84065. PubMed ID: 29137404
[TBL] [Abstract][Full Text] [Related]
14. Detection of collagen triple helix repeat containing-1 and nuclear factor (erythroid-derived 2)-like 3 in colorectal cancer.
Palma M; Lopez L; García M; de Roja N; Ruiz T; García J; Rosell E; Vela C; Rueda P; Rodriguez MJ
BMC Clin Pathol; 2012 Feb; 12():2. PubMed ID: 22321245
[TBL] [Abstract][Full Text] [Related]
15. High expression of FABP4 and FABP6 in patients with colorectal cancer.
Zhang Y; Zhao X; Deng L; Li X; Wang G; Li Y; Chen M
World J Surg Oncol; 2019 Oct; 17(1):171. PubMed ID: 31651326
[TBL] [Abstract][Full Text] [Related]
16. Clinical assessment and prognostic evaluation of tumor markers in patients with gastric cancer.
Jiexian J; Xiaoqin X; Lili D; Baoguo T; Ting S; Xianwen Z; Cunzhi H
Int J Biol Markers; 2013 Jun; 28(2):192-200. PubMed ID: 23787496
[TBL] [Abstract][Full Text] [Related]
17. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
[TBL] [Abstract][Full Text] [Related]
18. TM9SF4 expression in tumor tissues: a novel diagnostic biomarker for gastrointestinal tumors.
Guazzi P; Zocco D; Isajevs S; Zarovni N; Bianciardi L; Toots M; Sivins A; Leja M; Chiesi A; Lozupone F
Transl Cancer Res; 2020 Nov; 9(11):6652-6659. PubMed ID: 35117275
[TBL] [Abstract][Full Text] [Related]
19. [Preparation antibodies against recombinant bovine IFN-gamma and development of sandwich ELISA for bovine IFN-gamma detection].
Li C; Tan YD; Chen YY; Hu QY; Yan ZG; Qin B; Chao YJ; Chen HC; Guo AZ
Sheng Wu Gong Cheng Xue Bao; 2007 Jan; 23(1):40-5. PubMed ID: 17366886
[TBL] [Abstract][Full Text] [Related]
20. Clinical Significance of Serum p53 Antibody in the Early Detection and Poor Prognosis of Gastric Cancer.
Kunizaki M; Fukuda A; Wakata K; Tominaga T; Nonaka T; Miyazaki T; Matsumoto K; Sumida Y; Hidaka S; Yasutake T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
Anticancer Res; 2017 Apr; 37(4):1979-1984. PubMed ID: 28373470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
